Syros PharmaceuticalsSYRS
13F holders, Q2 2024 (June 30)70holders −5
11new positions
17sold out
4famous investors
$5.16avg. 13F price*
At the end of Q2 2024, 70 institutions reported holding Syros Pharmaceuticals Inc. (SYRS) in their 13F filings, down 5 from Q1 2024. 11 opened new positions and 17 sold out. The largest holders were Bain Capital Life Sciences Investors, LLC ($14.2M), Artal Group S.A. ($12.9M) and Adage Capital Partners Gp, L.L.C. ($10.7M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Syros Pharmaceuticals Inc.
- CUSIP
- 87184Q206
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $1.7M |
| Exits | 17 | $2.6M |
All 13F filers, Q1 2024 → Q2 2024: 780,668 shares bought and 1,313,961 shares sold, net −533,293 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 70 holders
| Bain Capital Life Sciences Investors, LLC | 1.56% | No change | 2,749,808 | $14.2M |
| Artal Group S.A. | 0.33% | No change | 2,505,013 | $12.9M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | No change | 2,071,914 | $10.7M |
| Samsara Biocapital, LLC | 1.93% | No change | 1,786,427 | $9.2M |
| Avidity Partners Management LP | 0.37% | No change | 1,673,538 | $8.6M |
| Point72 Asset Management | 0.03% | No change | 1,471,771 | $7.6M |
| Flagship Pioneering, LLC | 0.79% | No change | 1,293,849 | $6.7M |
| Vanguard Group Inc. | 0.00% | Add +4.3% | 968,217 | $5.0M |
| Opaleye Management Inc. | 1.04% | Add +9.9% | 865,443 | $4.5M |
| Deep Track Capital, LP | 0.13% | No change | 828,485 | $4.3M |
| Kennedy Capital Management LLC | 0.05% | Add +5.6% | 427,536 | $2.2M |
| Blue Owl Capital Holdings LP | 0.49% | No change | 340,855 | $1.8M |
| Walleye Capital LLC | 0.02% | Add +0.3% | 285,803 | $1.5M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.04% | Add +58.9% | 278,103 | $1.4M |
| ExodusPoint Capital Management, LP | 0.01% | Add +70.1% | 263,691 | $1.4M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -41.3% | 262,373 | $1.4M |
| BlackRock Inc. | 0.00% | Add +0.8% | 259,189 | $1.3M |
| Omega Fund Management, LLC | 0.96% | No change | 251,270 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +2.7% | 226,110 | $1.2M |
| Marshall Wace, LLP | 0.00% | Add +0.5% | 160,390 | $828K |
| Exome Asset Management LLC | 0.73% | New | 159,175 | $821K |
| DAFNA Capital Management LLC | 0.17% | No change | 135,850 | $701K |
| Renaissance Technologies | 0.00% | Reduce -2.0% | 117,435 | $606K |
| Perceptive Advisors LLC | 0.01% | No change | 116,754 | $602K |
| LPL Financial LLC | 0.00% | Add +0.7% | 76,625 | $395K |
| State Street Corp. | 0.00% | Add +18.8% | 69,430 | $358K |
| Millennium Management | 0.00% | Reduce -75.9% | 63,014 | $325K |
| LGT Capital Partners LTD. | 0.01% | No change | 55,000 | $284K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 51,500 | $266K |
| Northern Trust Corp. | 0.00% | Add +10.6% | 40,812 | $211K |
| Prelude Capital Management, LLC | 0.02% | New | 40,297 | $208K |
| Two Sigma Investments, LP | 0.00% | Reduce -41.0% | 40,266 | $208K |
| 1492 Capital Management LLC | 0.11% | Add +80.5% | 39,244 | $202K |
| Jane Street Group, LLC | 0.00% | Reduce -77.3% | 39,181 | $202K |
| Superstring Capital Management LP | 0.25% | New | 37,789 | $195K |
| Acadian Asset Management LLC | 0.00% | Add +101.5% | 34,578 | $178K |
| Susquehanna International Group, LLP | 0.00% | New | 30,005 | $155K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -79.6% | 28,159 | $145K |
| Citadel Advisors | 0.00% | New | 26,622 | $137K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 22,550 | $117K |
| UBS Group AG | 0.00% | Add +102533.3% | 21,553 | $111K |
| Certuity, LLC | 0.01% | New | 21,202 | $109K |
| Clarius Group, LLC | 0.01% | No change | 18,620 | $96K |
| Bank of America Corp. | 0.00% | Reduce -46.3% | 18,124 | $94K |
| Assenagon Asset Management S.A. | 0.00% | Reduce -90.7% | 15,873 | $82K |
| HighTower Advisors, LLC | 0.00% | Add +2.9% | 15,348 | $79K |
| Simplex Trading, LLC | 0.00% | Add +5973.7% | 14,091 | $72K |
| Corient Private Wealth LP | 0.00% | No change | 12,000 | $62K |
| Integrated Wealth Concepts LLC | 0.00% | No change | 10,000 | $52K |
| Morgan Stanley | 0.00% | Reduce -44.5% | 9,699 | $50K |
| Group One Trading LLC | 0.00% | New | 6,400 | $33K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 4,500 | $23K |
| Edmond DE Rothschild Holding S.A. | 0.00% | No change | 4,382 | $23K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 3,880 | $20K |
| Royal Bank of Canada | 0.00% | Add +159.6% | 3,421 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2902.1% | 2,852 | $15K |
| Redwood Wealth Management Group, LLC | 0.00% | New | 1,157 | $6K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 1,095 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -4.9% | 1,032 | $5K |
| National Bank of Canada | 0.00% | New | 859 | $4K |
| Russell Investments Group, Ltd. | 0.00% | No change | 750 | $4K |
| Rhumbline Advisers | 0.00% | No change | 659 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 549 | $3K |
| Wells Fargo & Company | 0.00% | Reduce -26.4% | 454 | $2K |
| Fifth Third Bancorp | 0.00% | No change | 129 | $666 |
| Activest Wealth Management | 0.00% | New | 87 | $449 |
| Sound Income Strategies, LLC | 0.00% | No change | 76 | $392 |
| Aviso Financial Inc. | 0.00% | — | 21 | $108 |
| PSI Advisors, LLC | 0.00% | No change | 13 | $67 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8 | $41 |
"% of holder's portfolio" is SYRS's weight in each manager's 13F, not the share of Syros Pharmaceuticals Inc. the manager owns.